Indian firm receives U.S. approval to market Simvastatin, a rival to Merck’s Zocor.
|
Generic drug makers get to keep 180-day exclusivity when the FDA de-lists patents.
|
Generics companies scramble as Merck’s cholesterol-lowering statin loses its patent.
|
A study shows that Pfizer’s Lipitor may help treat Alzheimer’s disease.
|